CoChat
Sign Up
Cited by 64

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease

Marchi, Cinzia, Adorni, Maria Pia, Caffarra, Paolo, Ronda, Nicoletta, Spallazzi, Marco, Barocco, Federica, Galimberti, Daniela, Bernini, Franco, Zimetti, Francesca·2019·Journal of Lipid Research
DOI 10.1194/jlr.p091033
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1194/jlr.p091033

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 14 references

Research works printed but not linked: 52

  1. Arenas, 2017, Intracellular cholesterol trafficking and impact in neurodegeneration, Front. Mol. Neurosci., 10, 382, 10.3389/fnmol.2017.00382 · DOI
  2. Dong, 2017, Integrated late onset Alzheimer's disease (LOAD) susceptibility genes: cholesterol metabolism and trafficking perspectives, Gene., 597, 10, 10.1016/j.gene.2016.10.022 · DOI
  3. Picard, 2018, Alterations in cholesterol metabolism-related genes in sporadic Alzheimer's disease, Neurobiol. Aging., 66, 180.e181, 10.1016/j.neurobiolaging.2018.01.018 · DOI · Paper page
  4. Wood, 2014, Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis, J. Neurochem., 129, 559, 10.1111/jnc.12637 · DOI · Paper page
  5. Dietschy, 2004, Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal, J. Lipid Res., 45, 1375, 10.1194/jlr.R400004-JLR200 · DOI · Paper page
  6. Chang, 2017, Cellular cholesterol homeostasis and Alzheimer's disease, J. Lipid Res., 58, 2239, 10.1194/jlr.R075630 · DOI · Paper page
  7. Quan, 2003, Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse, Brain Res. Dev. Brain Res., 146, 87, 10.1016/j.devbrainres.2003.09.015 · DOI · Paper page
  8. Ikonen, 2008, Cellular cholesterol trafficking and compartmentalization, Nat. Rev. Mol. Cell Biol., 9, 125, 10.1038/nrm2336 · DOI
  9. Koch, 2001, Characterization of four lipoprotein classes in human cerebrospinal fluid, J. Lipid Res., 42, 1143, 10.1016/S0022-2275(20)31605-9 · DOI · Paper page
  10. Chen, 2013, Cholesterol efflux is differentially regulated in neurons and astrocytes: implications for brain cholesterol homeostasis, Biochim. Biophys. Acta., 1831, 263, 10.1016/j.bbalip.2012.09.007 · DOI · Paper page
  11. Tarr, 2008, ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2, J. Lipid Res., 49, 169, 10.1194/jlr.M700364-JLR200 · DOI
  12. Yassine, 2016, ABCA1-mediated cholesterol efflux capacity to cerebrospinal fluid is reduced in patients with mild cognitive impairment and Alzheimer's disease, J. Am. Heart Assoc., 5, e002886, 10.1161/JAHA.115.002886 · DOI · Paper page
  13. Demeester, 2000, Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease, J. Lipid Res., 41, 963, 10.1016/S0022-2275(20)32039-3 · DOI · Paper page
  14. Vance, 2010, Formation and function of apolipoprotein E-containing lipoproteins in the nervous system, Biochim. Biophys. Acta., 1801, 806, 10.1016/j.bbalip.2010.02.007 · DOI · Paper page
  15. Dubois, 2007, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria, Lancet Neurol., 6, 734, 10.1016/S1474-4422(07)70178-3 · DOI · Paper page
  16. Dubois, 2014, Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, Lancet Neurol., 13, 614, 10.1016/S1474-4422(14)70090-0 · DOI · Paper page
  17. Gorno-Tempini, 2011, Classification of primary progressive aphasia and its variants, Neurology., 76, 1006, 10.1212/WNL.0b013e31821103e6 · DOI · Paper page
  18. Litvan, 1996, Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome), Neurology., 46, 922, 10.1212/WNL.46.4.922 · DOI
  19. Rascovsky, 2011, Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia, Brain., 134, 2456, 10.1093/brain/awr179 · DOI · Paper page
  20. Calero, 2018, A fast and cost-effective method for apolipoprotein E isotyping as an alternative to APOE genotyping for patient screening and stratification, Sci. Rep., 8, 5969, 10.1038/s41598-018-24320-3 · DOI
  21. Fukumoto, 2003, APOE epsilon 3/epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis, Exp. Neurol., 183, 249, 10.1016/S0014-4886(03)00088-8 · DOI · Paper page
  22. Favari, 2015, Cholesterol efflux and reverse cholesterol transport, Handb. Exp. Pharmacol., 224, 181, 10.1007/978-3-319-09665-0_4 · DOI
  23. Adorni, 2017, Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9, Ther. Clin. Risk Manag., 13, 1555, 10.2147/TCRM.S144121 · DOI
  24. Zimetti, 2017, Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction, J. Lipid Res., 58, 2051, 10.1194/jlr.P076463 · DOI
  25. Vigna, 2014, Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia, Nutr. Metab. Cardiovasc. Dis., 24, 777, 10.1016/j.numecd.2014.02.010 · DOI
  26. Favari, 2005, Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophages, FEBS Lett., 579, 6537, 10.1016/j.febslet.2005.10.042 · DOI · Paper page
  27. Greco, 2018, Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women, Nutr. Metab. Cardiovasc. Dis., 28, 822, 10.1016/j.numecd.2018.04.010 · DOI · Paper page
  28. Harrington, 2009, The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluid, Cerebrospinal Fluid Res., 6, 10, 10.1186/1743-8454-6-10 · DOI
  29. Havel, 1955, The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum, J. Clin. Invest., 34, 1345, 10.1172/JCI103182 · DOI
  30. Nordestgaard, 2015, Loss-of-function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease, Alzheimers Dement., 11, 1430, 10.1016/j.jalz.2015.04.006 · DOI · Paper page
  31. Courtemanche, 2018, PCSK9 concentrations in cerebrospinal fluid are not specifically increased in Alzheimer's disease, J. Alzheimers Dis., 62, 1519, 10.3233/JAD-170993 · DOI · Paper page
  32. Li, 2013, Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks, Arterioscler. Thromb. Vasc. Biol., 33, 1696, 10.1161/ATVBAHA.113.301373 · DOI · Paper page
  33. Rothblat, 2010, High-density lipoprotein heterogeneity and function in reverse cholesterol transport, Curr. Opin. Lipidol., 21, 229, 10.1097/MOL.0b013e328338472d · DOI
  34. Chiesa, 1998, Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice, Arterioscler. Thromb. Vasc. Biol., 18, 1417, 10.1161/01.ATV.18.9.1417 · DOI
  35. Zhou, 2019, Apolipoprotein A-I crosses the blood-brain barrier through clathrin-independent and cholesterol-mediated endocytosis, J. Pharmacol. Exp. Ther., 369, 481, 10.1124/jpet.118.254201 · DOI
  36. Talwar, 2016, Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease, J. Neurol. Sci., 360, 179, 10.1016/j.jns.2015.12.004 · DOI
  37. Song, 1997, Cerebrospinal fluid apo E and apo A-I concentrations in early- and late-onset Alzheimer's disease, Neurosci. Lett., 231, 175, 10.1016/S0304-3940(97)00558-2 · DOI
  38. Johansson, 2017, Reduced cerebrospinal fluid concentration of apolipoprotein A-I in patients with Alzheimer's disease, J. Alzheimers Dis., 59, 1017, 10.3233/JAD-170226 · DOI
  39. Kontush, 2004, Apolipoprotein Abeta: black sheep in a good family, Brain Pathol., 14, 433, 10.1111/j.1750-3639.2004.tb00088.x · DOI
  40. Gelissen, 2006, ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I, Arterioscler. Thromb. Vasc. Biol., 26, 534, 10.1161/01.ATV.0000200082.58536.e1 · DOI
  41. Sankaranarayanan, 2009, Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux, J. Lipid Res., 50, 275, 10.1194/jlr.M800362-JLR200 · DOI
  42. Koudinov, 2001, The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology?, Neurosci. Lett., 314, 115, 10.1016/S0304-3940(01)02263-7 · DOI
  43. Guyton, 1998, Novel large apolipoprotein E-containing lipoproteins of density 1.006–1.060 g/ml in human cerebrospinal fluid, J. Neurochem., 70, 1235, 10.1046/j.1471-4159.1998.70031235.x · DOI · Paper page
  44. Adorni, 2007, The roles of different pathways in the release of cholesterol from macrophages, J. Lipid Res., 48, 2453, 10.1194/jlr.M700274-JLR200 · DOI
  45. Landén, 1996, Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform, Dementia., 7, 273
  46. Dafnis, 2018, ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Abeta production independently of their cholesterol efflux capacity, Biochem. J., 475, 1839, 10.1042/BCJ20180068 · DOI
  47. Kim, 2007, Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation, J. Biol. Chem., 282, 2851, 10.1074/jbc.M607831200 · DOI · Paper page
  48. Eckert, 2013, Simvastatin alters membrane cholesterol distribution and beta-amyloid levels in brains of female APP751SL mice, Pharmazie., 68, 590
  49. Phan, 2014, Localization of amyloid beta (Abeta1–42) protofibrils in membrane lateral compartments: effect of cholesterol and 7-ketocholesterol, FEBS Lett., 588, 3483, 10.1016/j.febslet.2014.08.007 · DOI
  50. Kawarabayashi, 2004, Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease, J. Neurosci., 24, 3801, 10.1523/JNEUROSCI.5543-03.2004 · DOI · Paper page
  51. Whitehead, 2012, Membrane raft disruption results in neuritic retraction prior to neuronal death in cortical neurons, Biosci. Trends., 6, 183, 10.5582/bst.2012.v6.4.183 · DOI
  52. Sawamura, 2003, Promotion of tau phosphorylation by MAP kinase Erk1/2 is accompanied by reduced cholesterol level in detergent-insoluble membrane fraction in Niemann-Pick C1-deficient cells, J. Neurochem., 84, 1086, 10.1046/j.1471-4159.2003.01596.x · DOI

Cited by

Sorted by citations

See all 64

Metadata

Authors
Marchi, C., Adorni, M. P., Caffarra, P., Ronda, N., Spallazzi, M., Barocco, F., Galimberti, D., Bernini, F., & Zimetti, F.
ORCID
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2019-08
Volume
60
Issue
8
Pages
1449-1456
ISSN
0022-2275
DOI
10.1194/jlr.p091033
Cited by
64
References
14
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review